| A comprehensive review on vitiligo and its pharmacotherapy: Recent trends and future challenges Asmaa Moafa, Fahad Khalawi, Nagaraja Sreeharsha Ahead of print schedule 0, 0(0):0-0 DOI:10.4103/ijmo.ijmo_15_20
Approximately 1% of population in the world is affected by an intriguing skin depigmentation disorder, vitiligo. Typically, a vitiligo lesions are seen as white milky, nonscaly patches with separate edges. Vitiligo is caused by a selective loss of epidermal melanocytes. In vitiligo, there is impaired melanocyte regeneration and/or multiplication. Although the proportion of the population affected by this disease is very low, the disease is associated with a lot of social stigmas. This defect has an important effect on the life of the patient and still a persistent load.
|
| 10 | 3 | - |